Triethylamine → N-Cyclobutyl-N'-[1-(3-{1-ethyl-3-[(4-fluorophenoxy)methyl]-1H-pyrazol-5-yl}phenyl)-1-methylethyl]sulfamide

Participants

Reaction Steps

Prepared by the procedure of Example 1 Step 3 using the amine from Step 5 (100 mg, 0.28 mmol), Et3N (114 mg, 1.1 mmol) and cyclobutylsulfamoyl chloride (192 mg, 1.1 mmol) to yield, after purification by column chromatography on silica using 70% Et2O/iso-hexanes and then by normal phase preparative HPLC, the sulfamide (17.5 mg, 12%). 1H NMR (CDCl3, 360 MHz) δ 7.60-7.52 (2H, m), 7.44 (1H, t, J=7.6 Hz), 7.30 (1H, d, J=7.6 Hz), 6.97 (4H, app. d, J=6.3 Hz), 6.37 (1H, s), 5.06 (2H, s), 4.55 (1H, s), 4.12 (2H, q, J=7.3 Hz), 3.78 (1H, app. sextet, J=8.3 Hz), 2.45-2.35 (2H, m), 1.93-1.82 (2H, m), 1.75 (6H, s), 1.72-1.60 (2H, m), 1.44 (3H, J=7.3 Hz). MS (ES+) C25H31FN4O3S requires: 486, found: 487 (M+H+, 100%).

Provenance & Evidence